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3D anatomical and perfusion MRI 
for longitudinal evaluation of 
biomaterials for bone regeneration 
of femoral bone defect in rats
Emeline J. Ribot1, Clement Tournier2, Rachida Aid-Launais3, Neha Koonjoo1,  
Hugo Oliveira  2, Aurelien J. Trotier1, Sylvie Rey2, Didier Wecker4, Didier Letourneur3,  
Joelle Amedee Vilamitjana2 & Sylvain Miraux1
Magnetic Resonance Imaging (MRI) appears as a good surrogate to Computed Tomography (CT) scan 
as it does not involve radiation. In this context, a 3D anatomical and perfusion MR imaging protocol 
was developed to follow the evolution of bone regeneration and the neo-vascularization in femoral 
bone defects in rats. For this, three different biomaterials based on Pullulan-Dextran and containing 
either Fucoidan or HydroxyApatite or both were implanted. In vivo MRI, ex vivo micro-CT and histology 
were performed 1, 3 and 5 weeks after implantation. The high spatially resolved (156 × 182 × 195 µm) 
anatomical images showed a high contrast from the defects filled with biomaterials that decreased over 
time due to bone formation. The 3D Dynamic Contrast Enhanced (DCE) imaging with high temporal 
resolution (1 image/19 s) enabled to detect a modification in the Area-Under-The-Gadolinium-Curve 
over the weeks post implantation. The high sensitivity of MRI enabled to distinguish which biomaterial 
was the least efficient for bone regeneration, which was confirmed by micro-CT images and by a lower 
vessel density observed by histology. In conclusion, the methodology developed here highlights the 
efficiency of longitudinal MRI for tissue engineering as a routine small animal exam.
To evaluate the outcomes of new biomaterials on bone regeneration and vascularization and compare their in vivo 
efficiencies, non-invasive imaging techniques are required. The conventional imaging method for the analysis of 
bone repair is based on X-ray. Micro computed tomography (micro-CT) is an important tool to acquire quantita-
tive 3D data for in vivo biological studies1. The main advantages of the micro-CT lie in the high-spatial resolution, 
sensitivity to skeleton, and a low cost. However, its use is limited by the relatively poor contrast of soft tissue and 
by the radiation damage in patients or in experimental models. Furthermore, to our knowledge, only anatomical 
information can be obtained in vivo within the bone, whereas functional data are essential to characterize the 
newly formed tissue2, 3.
On the other hand, Magnetic Resonance Imaging (MRI) appears as a non-invasive and non-ionizing tech-
nique well suited to in vivo longitudinal evaluation of tissue repair following a grafting procedure. This technique 
is a good candidate, both to visualize biomaterials within bones and to obtain functional data on the angiogenesis 
within the defect. Indeed, cortical bone is a tissue with a well-known very short transversal relaxation time (T2), 
whereas biomaterials during early period after implantation possess very long T24. The balanced Steady-State 
Free Precession (bSSFP) sequence using a water frequency-selective (noted WS) binomial pulse was therefore 
employed since its contrast is related to T2/T1 of tissues, enabling the detection of defects filled with biomaterials 
with hyperintense signal. Other interesting features are the ability to acquire 3D images with high Signal-to-Noise 
Ratio (noted SNR) in short acquisition time. This is an important asset when cohorts of animals have to be 
scanned over time.
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In parallel, to obtain information on the functionality of newly-formed blood vessels, gadolinium-based 
contrast agents can be injected in the systemic circulation. The information obtained from Dynamic Contrast 
Enhancement (DCE) T1-weighted MR images have also been used to monitor angiogenesis over time within 
implanted constructs. However, most of the studies were performed in rabbits5–7, large animals8–11 and patients12, 
so as to limit voxel size and consequently shorten acquisition time. The spatial resolution has to be improved in 
small animals, like rats, as the structures are smaller. As an example, the femoral bone has a diameter of 3 mm 
in 8-week old rats. Nevertheless, small animals are very convenient to study critical-sized bone defects and then 
develop diagnosis techniques and innovative therapies.
In order to apply such studies onto small animals, high spatial and temporal resolutions are required. Indeed, 
heterogeneities within the biomaterials need to be assessed to evaluate the full recovery of the defect. High sen-
sitivity of the MR images is also necessary in order to evaluate variabilities between animals and to measure the 
efficiencies of several constructs depending on their different compositions.
Consequently, the objective of this work was to develop a non-invasive MR imaging protocol that can be 
applied on an experimental bone defect model in rats, to repetitively survey osteointegration of three biomaterials 
in bony sites. Indeed, our previous work has shown the osteoconductivity and osteoinductivity of a new macropo-
rous scaffold composed of natural hydrophilic polysaccharides supplemented with hydroxyapatite (Matrix-HA)4, 
13. This polysaccharide–based matrix can be supplemented with another natural sulfated polysaccharide extracted 
from brown algae, fucoidan(noted Fuco thereafter), having an heparin-like structure and reported to modulate 
the heparin-binding angiogenic growth factor (FGF-2) activity and to induce angiogenesis in vitro14–16. Three 
different matrices were thus investigated for their properties in bone repair and vascularization: Matrix-Fuco, 
Matrix-HA, Matrix-HA-Fuco. Both anatomical and functional MRI studies were performed to fully characterize 
Figure 1. (a) 3D WS-bSSFP in vivo representative images and (b) representative 2D pictures of the median 
region of the ex vivo Micro-CT 3D reconstructed femoral condyles, 1, 3 and 5 weeks after implantation of 
Matrix-Fuco, Matrix-HA, and Matrix-HA-Fuco matrices (arrows). The number of samples used for both 
techniques is indicated in Tables 1 and 2, respectively. The MRI signal from defects filled with Matrix-HA and 
Matrix-HA-Fuco disappeared 5 weeks after implantation. At week 5, mineralization was visible within the defect 
site for these latter conditions. Scale bar represents 1 cm.
Material Matrix-Fuco Matrix-HA Matrix-HA-Fuco
Week 1 5 4 6
Week 3 5 4 6
Week 5 5 4 6
Table 1. Number of samples used per group and per time-point for longitudinal MRI analyses.
Material Matrix-Fuco Matrix-HA Matrix-HA-Fuco
Week 1 8 9 15
Week 3 7 8 7
Week 5 9 7 8
Table 2. Number of samples used per group and per time-point for ex vivo micro-CT analyses.
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the new tissue in 3D within the bone defect. In parallel, ex vivo micro-CT and histology were also performed, 
in order to evaluate and quantify bone formation and compare the data from the different imaging modalities.
Results
Anatomical information of the newly regenerated tissue within the bone defect. In vivo MRI 
analysis. The WS-bSSFP sequence was performed to obtain anatomical information after implantation of bio-
materials in the rats. Contrarily to healthy bones that appear hypo-intense, all the defects filled with biomaterials 
were easily detected as hyper-intense areas within the bone marrow one week after the implantation (arrow in 
Figs 1a and S1 and S2). For the defects filled with Matrix-HA and Matrix-HA-Fuco biomaterials, the hyper-in-
tense signal disappeared over time, whereas the signal of the defect containing Matrix-Fuco remained even 5 
weeks after implantation (Fig. 1a).
The volume of the hyper-intense signal measured in the Matrix-HA rats decreased by 66.7% and 92.8% at 
week 3 and 5, respectively (Fig. 2a). Similar results were obtained for the Matrix-HA-Fuco biomaterial (57.3% 
and 91.7% at week 3 and 5, respectively). While no statistical difference between these two materials has been 
observed at week 5, the volume of the hyper-intense signals in the rats implanted with the Matrix-Fuco material 
had a different behavior as it remained similar over time (Fig. 2a).
Ex vivo Micro-CT analysis. One week after implantation, micro-CT images show a high signal coming from 
healthy bone and a lack of signal within the defect (Supplementary Fig. S1). None of the biomaterials could be 
detected on CT images at any time point.
In parallel to the MRI measurements, micro-CT images revealed, with time of implantation from week 1 to 
week 5, numerous spots of mineralized tissue inside the defects filled with Matrix-HA and Matrix-HA-Fuco, 
especially at week 5, whereas Matrix-Fuco filled defects only partially evidenced few spots of mineralized tissue 
(Fig. 1b). These observations were supported by the quantification of the Bone Volume to Total Volume (BV/TV) 
in the three groups of matrices (Fig. 2b). Mineralization increased over time for the three groups of matri-
ces. Significant differences of tissue mineralization was observed at week 3 and 5 between the Matrix-HA and 
Matrix-HA-Fuco groups, compared to Matrix-Fuco group.
Ex vivo Histological analysis. The qualitative and quantitative analyses obtained by MRI and micro-CT were 
confirmed by histological data and Masson’s Trichrome staining (Figs 3 and S1). We observed osteoid tissue and 
mineralized bone tissue around the beads of matrices of both Matrix-HA and Matrix-HA-Fuco, mainly at week 
3 and evidenced at week 5. For Matrix-Fuco group, few osteoid tissues were observed in some areas of the defect 
(Fig. 3) mainly at week 5, that correlated with the spots of mineralized tissue observed by micro-CT at the same 
time point (Fig. 3).
Figure 2. (a) Volume of the hyper-intense signal measured on the in vivo 3D WS-bSSFP images within the 
bone defects filled with the 3 biomaterials over weeks 1, 3 and 5. (b) BV/TV measurements from the ex vivo 
Micro-CT scans analysis. NS: Non Significant differences. Significant differences between biomaterials at 
each week are indicated with *p < 0.05 and **p ≤ 0.01 for week 3 and ##p ≤ 0.01 for week 5. Of note, the MRI 
volumes measured in Matrix-HA-Fuco filled defects were significantly different to each other at every time 
point. The MRI volumes measured in Matrix-HA filled defects at week 1 was significantly different to the ones 
obtained at week 3 and week 5. Similarly, the MRI volumes measured in Matrix-Fuco filled defects at week 5 was 
significantly different to the one obtained at week 1.
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The histomorphometry analysis demonstrated that the percentage of mature bone increased significantly over 
time of implantation when the Matrix-HA and Matrix-HA-Fuco were implanted into the defects (Fig. 4). Five 
weeks after implantation, these two biomaterials enabled to similarly promote bone formation into the defects.
However, when the Matrix-Fuco biomaterials were implanted into the defect, the amount of mature bone 
remained similar over time, even though bone tissue started to regenerate after 5 weeks (Fig. 4). This last result is in 
agreement with the timeline of bone regeneration within an empty defect, as already shown by Schlaubitz S et al.4.
Perfusion information of the newly regenerated tissue within the bone defect. In vivo DCE 
information. 3D T1-weighted MRI was performed with high spatial and temporal resolutions in order to fol-
low the rapid biodistribution of the Gd-DOTA in the rat bone defects after its intravenous injection. One week 
after the implantation of the matrices, the subsequent Gd-DOTA positive signal was detected, starting from the 
periphery of the defect to slowly diffuse to the center. The signal in the core of the defect gradually increased 
(Fig. 5). Forty-five minutes after the Gd-DOTA injection, the signals of the defect were still higher than before 
injection. This pattern was detected for all the defects. Over the weeks after the implantation, the contrast agent 
reached the center of the defect faster, and was cleared out over the 45 min course follow-up. The signal curve 
measured at 5-week post-implantation was similar to the one measured in the healthy bone for the Matrix-HA 
and Matrix-HA-Fuco materials. However, for the Matrix-Fuco materials, even at 5 weeks after implantation, the 
curve of the signal was still very different from the one of healthy bone.
To quantify these evolutions, the AUC over 45 minutes was measured within each voxel of the 3D T1-weighted 
MR images (Fig. 6a). Within a defect, two populations of voxels were detected depending on their AUC values. 
High AUC reflected a long remain time of the Gd-DOTA inside a voxel. On the contrary, low AUC reflected a fast 
wash-in/wash-out of the contrast agents in a voxel, similarly to the evolution of Gd-DOTA into the healthy bone 
tissue (Fig. 5). Due to the pixel-wise analyses, the amount of each population was quantified over time (Fig. 6b,c). 
The number of voxels with low AUC kept increasing over time, while the voxels with high AUC decreased in the 
Matrix-HA and Matrix-HA-Fuco filled defects. Indeed, the amount of voxels with low AUC corresponded to 
49.2% and 70.8% at week 3 and 5, and 42.2% and 76% at week 3 and 5, for the Matrix-HA and Matrix-HA-Fuco 
groups, respectively. In addition, the 3D AUC maps demonstrated that the periphery of the defects mostly con-
tained voxels with low AUC, whereas high AUC was mainly measured in the core of the defects. Furthermore, the 
thickness of this rim containing voxels with low AUC increased over time by 1.7 ± 0.2 mm and 2.2 ± 0.2 mm from 
week 1 to week 5, for the Matrix-HA-Fuco and Matrix-HA groups, respectively. On the contrary, the amount of 
voxels with low AUC remained similar over time for the Matrix-Fuco group (representing around 40% of the total 
amount of voxels within the defects) (Fig. 6b).
Figure 3. Representative images of histological staining of the bone defects that received the biomaterials at 
week 1, 3 and 5. Decalcified sections were stained with Masson’s Trichrome. Increase of osteoid, mineralized 
bone tissue and osteocytes are visible over time (arrows on the magnification images) around the beads of 
Matrix-HA and Matrix-HA-Fuco, especially at week 5. M: Matrix.
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Immunohistochemistry. Immunohistochemistry of CD31 blood vessel staining was performed at sacrifice after 5 
weeks of implantation (Fig. 7a). As indicated by the black arrows (Fig. 7a), blood vessels could be found through-
out the section and around the implanted material. As means to quantify the formation of blood vessels, we 
evaluated the number of vessels per mm2. As observed in Fig. 7b, a significant increase in terms of vessel density 
could be observed for the Matrix-HA-Fuco, in relation to Matrix-Fuco.
Discussion
This study is the first study to combine in vivo MRI, ex vivo microCT and histology on the same small animals 
with bone defects over time. In addition, its originality also relies on the 3D anatomical and 3D perfusion MRI 
images that were obtained.
Small animal models are getting more interest in the field of tissue engineering especially to develop bio-
materials for bone regeneration. Most of these studies are using Micro-CT imaging for longitudinal follow up. 
However, MRI appears to be a good surrogate due to its non-invasive properties, high contrast between tissues, 
the multi-parametric features in one exam and its translational potential combined with the development of 
musculo-skeletal MRI in clinics. Nevertheless, imaging of tissue engineering in rat models, especially for hind-
limb bone regeneration, has been poorly investigated4. Indeed, 3D high spatial and temporal resolutions are 
needed to follow the bone regeneration in the bone femoris.
In this study, a high magnetic field combined with specific phased array surface coils were used to per-
formed 3D anatomical and 3D perfusion imaging. Anatomical information were obtained by performing the 3D 
WS-bSSFP sequence. This T2-like high-contrast and high-SNR sequence was combined with a water-selective 
pulse to prevent high signal from adipose tissue, which is the main component of the bone marrow. This enabled 
to detect with high contrast any bone defects filled with biomaterials and to measure their signal longitudinally. 
Over time, this hyper-intense signal decreased, reflecting the formation of new bone tissue having very short T2 
inside the defects. The sensitivity of this sequence enabled to demonstrate the efficiency with time of biomaterials 
in regenerating bone tissue.
Even though, no direct bone quantification could be performed on the MRI images, the measurement of the 
volume of the WS-bSSFP hyper-intense signal inversely correlated with the bone volume (BV/TV) calculated by 
micro-CT. Consequently, an indirect quantification of bone regeneration could be estimated using WS-bSSFP 
with no radiation involvement. In addition, the 3D WS-bSSFP sequence could be a good surrogate to micro-CT 
as it can be applied on small and large animals and on humans at high and clinical magnetic fields, even in the 
case of poor field homogeneity through the use of the Sum-Of-Square reconstruction17. The bSSFP sequence is 
already available on most of the clinical scanners, but is rarely performed in 3D due to banding artifacts. At mag-
netic fields lower than 4.7 T, only 1 or 2 bSSFP images are needed to suppress these artifacts due to a better field 
Figure 4. Percentage of bone formation within the implanted matrices over time of implantation. The 
quantification was performed from Trichrome Masson staining slides (n = 3) on the defects filled with the 
three groups of biomaterials over weeks 1, 3 and 5. Significant differences between biomaterials at each week 
are indicated with *p < 0.05 for week 3 and ##p ≤ 0.01 for week 5. Of note, the percentage of bone formation 
obtained on the Matrix-HA-Fuco filled defects were significantly different to each other at each time point. The 
percentage obtained on the Matrix-HA filled defects at week 1 was significantly different to the ones obtained 
at week 3 and week 5. Similarly, the percentage obtained on the Matrix-Fuco filled defects at week 5 was 
significantly different to the ones obtained at week 1 and week 3.
www.nature.com/scientificreports/
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homogeneity. Consequently, acquisition time should be shorter than 2 minutes when applied on humans than in 
the current study, making the sequence of a huge interest for bone tissue engineering.
Anatomical information is essential in order to evaluate bone regeneration, but the functionality of the 
new tissue needs to be assessed. Angiogenesis is a crucial event that is necessary to generate viable bone tissue. 
Although iodine-based contrast agents can be injected intravenously to detect blood vessels18, micro-CT angiog-
raphy is not trivial due to long exposures to radiations. Consequently, most of these studies are performed ex-vivo. 
On the contrary, perfusion MRI is a clinical routine technique and is often applied for small animal imaging using 
2D T1-weighed MR sequences19, 20. In our case, 3D high spatial resolution was necessary in order to discriminate 
differences of perfusion within the defects. In addition, 3D high temporal images were performed to detect the 
rapid biodistribution of the contrast agent in the defects filled with the biomaterials. Contrarily to human imag-
ing, the Arterial Input Function (AIF) was not measured in the current study, because of its poor accuracy in 
small animals. Consequently, the AUC was measured in order to discriminate perfusion states between different 
matrices-filled defects. Indeed, AUC already enabled to distinguish bladder constructs containing high and low 
amount of VEGF6.
Figure 5. Representative MR ΔSignal (subtracted from the signal measured before injection) over time after 
the intravenous injection of Gd-DOTA (black arrow) at week 1, 3 and 5 after implantation of Matrix-Fuco (a), 
Matrix-HA (b), and Matrix-HA-Fuco (c) matrices.
Figure 6. (a) 3D parametric AUC maps of the bone defects that received the biomaterials. A slice showing each 
defect at each time point was extracted from the 3D maps. For each biomaterial group, the same rat is displayed 
over weeks 1, 3 and 5. The white arrows show the defect. The color scale represents the AUC values between 
0 and 0.05. (b) 3D rendering of each biomaterial defect extracted and magnified at weeks 1, 3 and 5 post-
implantation. Voxels with high AUC values are colored in green and voxels with low AUC values are colored in 
blue. The small inserts are 2D slices extracted from the 3D AUC maps, located at the center of the defect. The 
amount of fast-perfused voxels (with low AUC) increased over time in the Matrix-HA and Matrix-HA-Fuco 
filled defects. In contrast, no change with time was measured in the defects filled with Matrix-Fuco biomaterial. 
(c) Quantitative analysis of the percentage of pixels with high (green) and low (blue) AUC from the extracted 
Volume-of-Interest (VOI) for the 3 different biomaterials at weeks 1, 3 and 5. Values are means ± Standard 
Deviations. Significant differences between each week are indicated with *p < 0.05 and **p ≤ 0.01. Of note, 
the percentage obtained on the Matrix-HA-Fuco filled defects at week 5 was significantly different to the ones 
obtained at week 1 and week 3. Similarly, the percentage obtained on the Matrix-HA filled defects at week 1 was 
significantly different to the ones obtained at week 5. On the contrary, the percentages obtained on the Matrix-
Fuco filled were not significantly different at any time point.
www.nature.com/scientificreports/
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The high resolution of the 3D DCE-MR images enabled to measure AUC heterogeneities within each defects. 
Indeed, the analysis of each entire defect showed that the AUC were smaller at the peripheries of the defects com-
pared to large AUC that were located in voxels of the defect cores. These results were also obtained by Beaumont 
et al., where a calvaria model was studied using DCE-MRI in rabbits21. Like in our study, they measured two AUC 
values after Gd-DOTA injection depending on the core and the periphery of the materials. Imaging at high mag-
netic field (7 T here versus 1.5 T in Beaumont et al.) enabled to increase the spatial resolution (195 × 312 × 375 um 
versus 390 × 781 × 3000 um, respectively) without affecting SNR in order to study small defects (3.5 mm diameter 
in the rats versus 15 mm in the rabbits). Consequently, the current 3D MRI perfusion protocol would be of great 
interest to study and compare the neo-vascularisation in innovative bone substitutes.
In the field of bone tissue regeneration, the reconstruction of large volume defects remains challenging because 
of a lack of vascularization22. Several advanced techniques have been developed to overcome these limitations23 
including production of tissue-engineered constructs that combine scaffolds with mesenchymal stems cells and/
or endothelial progenitor cells24, 25, osteoinductive factors26, 27, or angiogenic growth factors28. However, their use 
is often associated with excessive inflammation, uncontrolled drug delivery, high costs29, and specific regulations 
and production for cell-based approaches30. Consequently, innovative cell-free and growth factor-free bioma-
terials able to promote both bone formation and vascularization are still expected. In this context, we have pre-
viously described osteoconductivity and osteoinductivity of a ready-to-use macroporous polysaccharide-based 
scaffold supplemented with hydroxyapatite (Matrix-HA)4, 13. Using the 3D in vivo MRI, we were able to per-
form here a longitudinal follow up of this matrix in bone repair and the comparison with new matrices supple-
mented with fucoidan, having heparin-like angiogenesis properties14–16. Our results indicated that the inclusion 
of fucoidan alone in the matrix was not sufficient to observe a significant repair process or neo-vascularization. 
Interestingly, in vivo 3D WS-bSSFP MRI clearly indicated a bone repair process using both the Matrix-HA and 
Matrix-HA-Fuco. In addition, the 3D MRI perfusion data correlated with vascularization observed by histology 
after sacrifice. In fact, one week after implantation of the biomaterials, a very slow accumulation of the contrast 
agent was observed from the periphery to the core of the biomaterials. This pattern, observed for the defects filled 
with the three matrices, was mostly due to not-yet vascularized defects. In that case, Gd-DOTA was supplied 
to the defects through already existing bone marrow vessels, and then slowly diffused inside the defects. After 
5 weeks, Gd-DOTA reached the core of the defect more rapidly in the cases of Matrix-HA matrices. With these 
materials, the evolution of the signal was similar to the one measured in healthy bone (Fig. 4). This could be 
attributed to the formation of new blood vessels within these defects. This was confirmed by immunohistochem-
istry, showing a higher density of blood vessels in the Matrix-HA matrices-filled defects. This is in agreement 
with previous studies that demonstrated that AUC correlated well with micro-vascularity of a bladder acellular 
matrices5–7. Consequently, the high sensitivity of the 3D DCE-MRI technique enabled to characterize the perfu-
sion heterogeneity between defects filled with biomaterials promoting or not neo-vascularization and within each 
defect, and also the evolution of the perfusion overtime.
The current protocol might be applicable to a wide range of biomaterials. Indeed, hydrogels31 or chitosan-based 
hydrogels32 has already been detected as hyper-intense signals on MR images. Consequently, it is expected that 
the same anatomical and perfusion images can be performed on these materials. Nevertheless, it might be less 
efficient when materials are more solid than the ones used in this study, for example the ones containing titanium. 
Indeed, as the MR signal would be severely affected, the contrast of the materials with the healthy bone would 
be largely reduced. This might prevent an accurate volume delineation. To circumvent this problem, specific MR 
sequences might be employed, like the ones using Ultra-short Echo Time (UTE).
Figure 7. Immunohistochemistry evaluation of CD31 expression. (a) Representative images of CD31 staining 
of vessels in the three groups of implanted matrices (scale bar = 100 µm). (b) Quantification of vessel density 
inside the implanted matrices at 5 weeks post implantation (n = 6; Average ± SD). NS and **denote Non 
Significant and p < 0.01, respectively.
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To conclude, MRI has a tremendous potential for bone tissue engineering applications and the follow-up of 
the newly bone tissue regenerating within a defect. Both qualitative and quantitative data obtained by ex vivo 
Micro-CT, ex vivo histology and in vivo MRI indicated similar effects in terms of bone tissue regeneration, vascu-
larization and perfusion. Due to the non-invasiveness of MRI, less animals were also used for imaging bone tissue 
formation compared to histological analysis. Taken together, MRI can be used as an alternative to micro-CT 
and histology/immunohistochemistry for preclinical bone tissue engineering studies, and is of great interest to 
non-invasively follow bone repair and vascularization in humans.
Materials and Methods
Preparation and characterization of polysaccharide-based porous beads. Three polysaccha-
ride-based matrices were prepared using previously described methods4, 13, 16. Briefly, pullulan and dextran dis-
solved in water at a final concentration of 30% w/v (Pullulan, Mw 200,000, Hayashibara, Japan; Dextran, Mw 
500,000, Pharmacosmos, Danmark) were chemical cross-linked with sodium trimetaphosphate (STMP, 25% (w/v), 
Sigma) under alkaline conditions. Fucoidan extracted from Fucus vesiculosus of medium molecular weight (Sigma-
Aldrich, 10% w/w), Hydroxyapatite obtained by wet precipitation of a 0.6 M solution of phosphoric acid and a 
1 M solution of calcium hydroxide13, or both were added to the polysaccharide solution to obtain Matrix-Fuco, 
Matrix-HA or Matrix-HA-Fuco. Sodium chloride (54% (w/w)) was also added as porogen agent to prepare porous 
scaffolds. Scaffolds were obtained after freeze-drying in the form of dried 300–500 µm beads as previously reported4.
Animal models. Animal experiments were performed in accordance with the “Principles of Laboratory 
Animal Care” recommended by the National Society for Biomedical Research in France. Interventions were car-
ried out in an accredited animal facility (authorization no. A33-063-917) at the University of Bordeaux, under 
authorization no. 5012032-A of the French Ministry of Agriculture and were approved by the Animal Ethic 
Committee of the University of Bordeaux.
Anesthesia was induced with a mixture of 4% isoflurane/Air 1–2 L/min (Baxter, Deerfield/IL, USA) and was 
maintained at 2% isoflurane/Air 0.8 L/min during the implantation. A stable body temperature was assured by 
the use of a heating device. Medial defects of 3.5 mm diameter and 4 mm depth were introduced in left and/or 
right femoral condyles of female Wistar RjHan rats at 10 weeks of age weighting 250–300 g (Janvier, Le Genest, 
France) using a dental microdrill (Thomas, France). Bone defects of about 38 mm3 were rinsed with physiological 
solution NaCl 0.9% (w/v). The defect was filled with dry beads of Matrix-Fuco, Matrix-HA, and Matrix-HA-Fuco, 
leaving enough time for the beads to hydrate with the blood invading the defect and, as a consequence, to increase 
slightly in size. The scaffolds remained solid enough to stay inside the defect. Therefore, no membrane was needed 
to avoid leakage of the biomaterial. Absorbable Vicryl sutures were performed on lateral muscles before clos-
ing the cutaneous plan with non-absorbable prolene sutures and suture clips. To assure analgesia, 0.3 mg/kg of 
buprenorphine (Vetergesic Multidose, Alstoe Veterinary, York, UK) was administered subcutaneously to each rat 
30 min prior to the procedure as well as 24 hours afterwards. Additionally, animals were kept under free access to 
0.2 mg/mL of Ibuprofen (Advil, Pfizer, Canada) 3 days prior to surgery and during 1 week after surgery through 
the drinking water.
The number of animals used for the MRI and micro-CT experiments are summarized in Tables 1 and 2, 
respectively. Animals were sacrificed by lethal injection (200 mg/animal) of sodium pentobarbital (Ceva, France).
MRI study. A total of 15 rats were used for the MRI longitudinal study. These rats were implanted in only one 
limb and five implants were imaged per group of biomaterials (Table 1). Longitudinal in vivo MRI was performed 
on the same rats from each group, 1, 3 and 5 weeks post-implantation. The MR images were acquired on a hori-
zontal 7 T magnet (Bruker, Biospec, Germany). The system was equipped with a 12 cm gradient insert capable of 
660 mT/m maximum strength and 110 µs rise time. The rat knees were imaged using an emission 4-phased array 
surface coil. Rats were anesthetized with isoflurane (1.5% in air). The respiration rate was monitored using an air 
balloon place on top of the lungs (SA Instruments Inc., NY, USA).
Anatomical 3D imaging. A 3D bSSFP sequence was used in which the usual radiofrequency pulse was 
replaced by a water frequency-selective binomial pulse (containing 5 hermite sub-pulses). Each pulse lasted 
150 μs, the interpulse delay was set to 200 μs, the intensities of the pulses followed the schematic 1-2-3-2-1. The 
slice selection gradient was removed. The other sequence parameters were as follow: TE/TR = 1.9/5.1 ms; recep-
tion bandwidth = 75 kHz; FOV = 30 × 35 × 25; matrix = 192 × 192 × 128; 4 phase offsets; FA = 27°; 2 averages; 
Total acquisition time = 17 min. The 3D images were reconstructed after a “Sum-Of-Square” of the 4 offsets33.
3D DCE-MRI. DOTAREM (Guerbet, France) containing Gd-DOTA, a T1-contrast agent commonly used 
in clinics, was intravenously injected at each scanning session (400 µL of a dose of 100 mM). 3D T1-weighted 
images were acquired before and after the injection with the following parameters: FOV = 25 × 30 × 12; 
matrix = 128 × 96 × 32; TE/TR = 1.9/6.5 ms; flip angle = 30°; rBW = 75 kHz. One image was acquired in 19 s and 
the clearance of Gd-DOTA was followed over 45 min.
Image Analysis. The volume of the hyperintense signal located within the defect and detected on the ana-
tomical WS-bSSFP images was measured using the Amira software. For this purpose, a 3D region of interest 
(ROI) was manually drawn to englobe voxels with signal superior to the signal of the surrounding healthy bone 
(signal of 43.3 ± 11.3 a.u.).
The analyses of the DCE-MRI were performed on a pixel-wise basis using the Matlab software (Mathworks 
Inc., France). To minimize variabilities between animals, the signal to noise ratio (SNR) was normalized to the 
signal from the calf muscle and to the noise. For this purpose, independent ROIs were drawn in the muscle and 
outside of the animal’s tissue. Finally, a 3D cylinder-shaped mask was applied on the images acquired at week 1 
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in order to select the defect within the healthy bone (healthy bone represented 36.4% ± 2.9 of the total amount of 
the voxels within the mask). This mask was applied on the images acquired at week 1, 3 and 5 after implantation.
The area under the SNR curve for 45 min after the contrast agent injection (AUC) was computed for each 
pixel within the mask. Histograms representing the amount of voxels in function of the AUC values were created 
in order to manually set a threshold separating high versus low AUC values. Low AUC values were identified as 
similar to the AUC of healthy bone. The threshold was determined for every rat at each time point in order to 
counteract differences in arrival time of the contrast agent to the defects due to the DOTAREM manual injection.
Micro-Computed Tomography study. 18 rats were implanted in both sides (right and left femoral con-
dyles) per group of matrices. The bones were extracted for ex vivo micro-CT at week 1, 3 and 5 after implantation 
into the condyles. Table 2 summarizes the number of samples used for each time point and for the three groups of 
matrices after the exclusion of the ones exhibiting spontaneous fractures after surgery.
The X-ray microtomographic equipment used in this study was a Quantum FX Caliper (Life Sciences, Perkin 
Elmer, Waltham, MA). The X-ray source was set at 90 V and 160 μA. Samples were scanned up to a Field of 
View of 10 mm diameter and were imaged with a 3D isotropic voxel size of 20 μm. Full 3D high-resolution raw 
data were obtained by rotating both the X-ray source and the flat panel detector 360° around the sample, with 
a rotation step of 0.1° (scanning time: 3 min). The corresponding 3600 image projections were then automati-
cally reconstructed (RigakuSW software, Caliper) into a Dicom stack of 512 files using standard back-projection 
techniques (reconstruction time: less than a minute). The three-dimensional (3D) images of samples were built 
by stacking 512 cross sections obtained by X-ray microtomography. The resulting 3D files were composed of 
grey-level images where lowest grey/dark pixels represented empty spaces and highest grey/bright pixels stood for 
the densest materials. Three-dimensional analyses were performed using eXplore MicroView® software (General 
Electric Healthcare, Milwaukee, WI). Reconstruction of the region of interest was performed. Bone volume (BV) 
and total volume (TV) volume were measured for each group.
Histological observation. Fixed samples in 4% (w/v) paraformaldehyde (PFA) were decalcified 
(Decalcifiant DC1, Labonord, France), dehydrated and paraffin-embedded. Transversal sections (7–9 µm thick-
ness) were prepared and treated with Masson Trichrome for mineralized bone and osteoid tissue staining. The 
sections were analyzed with an Eclipse 80i light microscope (Nikon, Japan). Pictures were captured using a DXM 
1200 C (Nikon, Japan) CCD camera.
Quantification of the bone formation was performed by measuring the amount of voxels containing collagen 
matrix of matured bone within the defects. For this purpose, using a Matlab script entitled ≪ L*a*b* Color 
Space ≫, a mask was drawn to encircle each defect within the bone. Then, mature bone was detected through 
a reference color value manually determined by the operator. Based on this reference, the script automatically 
attributed or not each pixel to this referenced color. Then, the number of voxels corresponding to collagen matrix 
of mature bone was calculated. This amount was normalized to the total amount of voxels covering the bone 
defect. This procedure was applied on 3 slides at each time point and for each biomaterials.
Immunohistochemistry analysis. Immunohistochemistry for CD31 was performed as previously 
described34. Briefly, 7–9 µm thickness paraffin sections were cut, deparafinized, rehydrated using ethanol gradients 
and placed in PBS. Antigen recovery was performed using a proteinase K (Roche, France) digestion procedure 
and then endogenous peroxidase was quenched using 3% (v/v) hydrogen peroxide for 5 min at room tempera-
ture (RT). Tissues were blocked with 2% horse serum, in PBS, for 30 min at RT. Primary antibody against CD31 
(NB100–2284, Novus Biologicals, Bio-Techne, France) was used at 1:100 in 2% (w/v) BSA in PBS, and incubated 
overnight at 4 °C. After two washes with PBS, the anti rabbit Impress kit (VectorLabs, USA) was used according to 
the manufacturer’s instructions. Specific staining was obtained using the 3,3′-diaminobenzidine staining solution 
(VectorLabs, USA). Counterstaining was performed using Mayer’s haematoxylin. Samples were then mounted 
using Pertex medium (Sigma). Sample imaging was performed using a microscope (Nikon Eclipse 80i) equipped 
with a digital camera (Nikon Dxm 1200C). Sample analysis was performed at three different sample positions and 
a total of six animal samples were assessed per time point and condition. Vessel quantification was performed 
using ImageJ analysis, and the number of vessels was determined and normalized to the area of the defect.
Statistical Analysis. The Graphpad Prism 5.0 software was used. A D’Agostino and Pearson omnibus nor-
mality test was used in order to test if data obeyed to a Gaussian distribution. Statistically significant differences 
between several groups were analyzed by the one-way ANOVA test followed by the Bonferroni post test. A p value 
lower than 0.05 was considered to be statistically significant.
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